Canadian Heart Research Centre

ACTIVE

200-259 Yorkland Rd, North York, Ontario, Canadawww.chrc.netPrivate101–250 employeesEstablished: 1998-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1998

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

16.7%

Phase 3

16.7%

Phase 4

16.7%

Trial Status Distribution

Completed

83.3%

Terminated

16.7%

Clinical Trials

Trials sponsored by this organization (6)

Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE )

Completed

observational

Dec 20052,500 participants

Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)

Phase 3

Completed

interventional

Sep 2005391 participants

Routine Angioplasty and Stenting After Fibrinolysis for Acute Myocardial Infarction

Not Applicable

Completed

interventional

Jul 20041,200 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations

Canadian Heart Research Centre

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (6)

North American Acute Coronary Syndrome (ACS) Reflective III Pilot

Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada

Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)

Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE )

Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)

Routine Angioplasty and Stenting After Fibrinolysis for Acute Myocardial Infarction

Approvals

News